Reply To: Adjuvant Immunotherapy in stage IIIA patients

[Anonymous]

Hi Lisa,
Thus far, we have not been offering nivolumab to Stage IIIA patients since the trials have not included that population. However, I hope this can be revisited in the future and I would be very interested in what others are doing at their institutions.